Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells

by Anna R. Michmerhuizen, Anna R. Michmerhuizen, Anna R. Michmerhuizen, Benjamin Chandler, Benjamin Chandler, Benjamin Chandler, Eric Olsen, Kari Wilder-Romans, Leah Moubadder, Meilan Liu, Andrea M. Pesch, Andrea M. Pesch, Andrea M. Pesch, Amanda Zhang, Cassandra Ritter, S. Tanner Ward, Alyssa Santola, Shyam Nyati, James M. Rae, James M. Rae, James M. Rae, Daniel Hayes, Daniel Hayes, Felix Y. Feng, Daniel Spratt, Daniel Wahl, Joel Eisner, Lori J. Pierce, Lori J. Pierce, Corey Speers, Corey Speers
Published 2020-02-01

Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer

by Daniel L. Hertz, Karen Lisa Smith, Yuhua Zong, Christina L. Gersch, Andrea M. Pesch, Jennifer Lehman, Amanda L. Blackford, N. Lynn Henry, Kelley M. Kidwell, James M. Rae, Vered Stearns
Published 2021-06-01